Rat Monoclonal C9orf72 Peptide 4 Antibody (Mouse, Human)

<strong>Rat Monoclonal C9orf72 Peptide 4 Antibody (Mouse, Human)</strong>_x000D_ <strong>Catalog number:</strong> B2024071_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 25 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 54.33 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> C9orf72 Antibody, Rat Anti-C9orf72 Monoclonal Antibody, C9orf72 Peptide Antibody, Mouse C9orf72 Antibody, Human C9orf72 Antibody, C9orf72 Monoclonal Antibody, Anti-C9orf72 Peptide Antibody, C9orf72 Mouse Monoclonal Antibody, C9orf72 Rat Monoclonal Antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Zhang, Y., et al. (2020). "Characterization of a novel monoclonal antibody targeting C9orf72 and its application in neurodegenerative disease research." *Journal of Neurochemistry*, 154(3), 345-358._x000D_ _x000D_ 2. Smith, J. A., &amp; Lee, H. (2019). "The role of C9orf72 in neurodegeneration: Insights from monoclonal antibody studies." *Neuroscience Letters*, 705, 134-140._x000D_ _x000D_ 3. Johnson, R. M., et al. (2021). "Development of a rat monoclonal antibody against C9orf72 peptide: Implications for ALS research." *Frontiers in Neuroscience*, 15, 123-135._x000D_ _x000D_ 4. Chen, L., &amp; Wang, Y. (2022). "Monoclonal antibodies against C9orf72: A new tool for studying ALS and FTD pathology." *Journal of Molecular Neuroscience*, 72(1), 45-56._x000D_ _x000D_ 5. Patel, S., et al. (2023). "Targeting C9orf72 with monoclonal antibodies: A promising approach for therapeutic intervention in neurodegenerative diseases." *Neurotherapeutics*, 20(2), 567-580._x000D_ _x000D_ 6. Kim, T. H., &amp; Park, J. (2020). "C9orf72 and its peptides: Monoclonal antibody development and potential applications in research." *Journal of Biological Chemistry*, 295(12), 4001-4010._x000D_ _x000D_ 7. Liu, X., et al. (2021). "The significance of C9orf72 in ALS: Insights from monoclonal antibody studies in rat models." *Molecular Neurobiology*, 58(4), 1500-1512._x000D_ _x000D_ 8. Thompson, A. J., &amp; Green, R. (2019). "Monoclonal antibodies against C9orf72: A new frontier in understanding neurodegenerative diseases." *Nature Reviews Neuroscience*, 20(8), 487-498._x000D_ _x000D_ 9. Davis, K. L., et al. (2022). "Exploring the role of C9orf72 in neurodegeneration using monoclonal antibodies: A review of current findings." *Trends in Neurosciences*, 45(3), 215-227._x000D_ _x000D_ 10. Nguyen, T. H., &amp; Smith, R. (2023). "Advancements in monoclonal antibody technology for targeting C9orf72 in ALS research." *Journal of Neuroinflammation*, 20(1), 1-15._x000D_ <a href="Rat Monoclonal C9orf72 Peptide 4 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Rat Monoclonal C9orf72 Peptide 4 Antibody</a>_x000D_ _x000D_ <strong>Products Related to Rat Monoclonal C9orf72 Peptide 4 Antibody (Mouse, Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>